Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$17.78 - $42.39 $533,400 - $1.27 Million
-30,000 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$47.84 - $64.34 $239,200 - $321,700
5,000 Added 20.0%
30,000 $1.76 Million
Q3 2021

Nov 15, 2021

BUY
$59.27 - $95.73 $1.48 Million - $2.39 Million
25,000 New
25,000 $1.48 Million
Q2 2021

Aug 16, 2021

SELL
$67.25 - $92.52 $2.69 Million - $3.7 Million
-40,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$72.16 - $117.4 $2.16 Million - $3.52 Million
30,000 Added 300.0%
40,000 $3.3 Million
Q4 2020

Feb 16, 2021

BUY
$38.09 - $100.95 $380,900 - $1.01 Million
10,000 New
10,000 $909,000

Others Institutions Holding FATE

About FATE THERAPEUTICS INC


  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $260M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Sg3 Management, LLC Portfolio

Follow Sg3 Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg3 Management, LLC with notifications on news.